Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Cell Host & Microbe|February 26, 2025
Bacteria exploit viral dormancy to establish CRISPR-Cas immunityNicholas C Keith, Rhett A Snyder, Chad W Euler, et al.Cell Reports|March 1, 2024
Anti-CRISPR proteins trigger a burst of CRISPR-Cas9 expression that enhances phage defenseRachael E Workman, Marie J Stoltzfus, Nicholas C Keith, et al.Nature Microbiology|July 12, 2024
A dynamic subpopulation of CRISPR-Cas overexpressers allows Streptococcus pyogenes to rapidly respond to phageMarie J Stoltzfus, Rachael E Workman, Nicholas C Keith, et al.Cell|January 9, 2021
A natural single-guide RNA repurposes Cas9 to autoregulate CRISPR-Cas expressionRachael E Workman, Teja Pammi, Binh T K Nguyen, et al.Antibiotics (Basel, Switzerland)|February 15, 2020
Gram-Negative Bacterial LysinsChandrabali Ghose, Chad W EulerNature|March 30, 2017
CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunityJoshua W Modell, Wenyan Jiang, Luciano A MarraffiniFrontiers in Microbiology|April 4, 2022
PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin InfectionsRyan D Heselpoth, Chad W Euler, Vincent A FischettiAntimicrobial Agents and Chemotherapy|November 12, 2025
Second-generation lysocins as therapeutics for treating <i>Pseudomonas aeruginosa</i> infectionsRyan D Heselpoth, Chad W Euler, Vincent A FischettiGenes & Development|June 21, 2011
A DNA damage checkpoint in Caulobacter crescentus inhibits cell division through a direct interaction with FtsWJoshua W Modell, Alexander C Hopkins, Michael T LaubAntimicrobial Agents and Chemotherapy|September 23, 2015
Using a Novel Lysin To Help Control Clostridium difficile InfectionsQiong Wang, Chad W Euler, Aurelia Delaune, et al.Pageof 5